C72.5 Malignant neoplasm, other and unspecified cranial nerves - analogs
| Description «C72.5 Malignant neoplasm, other and unspecified cranial nerves» | ||||||
|
||||||
Начиная работу с сервисом, вы принимаете соглашение пользователя. Kiberis do not replace the doctor!
- 24% Compare C71.9 Malignant neoplasm, brain, unspecified
- 24% Compare C69-C72 Malignant neoplasms of the eye, brain and other parts of the central nervous system
- 23% Compare C71.8 Malignant neoplasm, overlapping lesion of brain
- 23% Compare C70.0 Malignant neoplasm, cerebral meninges
- 23% Compare C72 Malignant neoplasm of spinal cord, cranial nerves and other parts of central nervous system
- 23% Compare C72.8 Malignant neoplasm, overlapping lesion of brain and other parts of central nervous system
- 23% Compare C71 Malignant neoplasm of brain
- 23% Compare C79.3 Secondary malignant neoplasm of brain and cerebral meninges
- 20% Compare C54 Malignant neoplasm of corpus uteri
- 20% Compare C53.8 Malignant neoplasm, overlapping lesion of cervix uteri
- 20% Compare C54.8 Malignant neoplasm, overlapping lesion of corpus uteri
- 20% Compare C53.9 Malignant neoplasm, cervix uteri, unspecified
- 20% Compare C53 Malignant neoplasm of cervix uteri
- 20% Compare C54.0 Malignant neoplasm, isthmus uteri
- 20% Compare C53.1 Malignant neoplasm, exocervix
- 20% Compare C54.3 Malignant neoplasm, fundus uteri
- 20% Compare C57.1 Malignant neoplasm, broad ligament
- 20% Compare C53.0 Malignant neoplasm, endocervix
- 20% Compare C57.2 Malignant neoplasm, round ligament
- 16% Compare C54.9 Malignant neoplasm, corpus uteri, unspecified
- 16% Compare D06 Carcinoma in situ of cervix uteri
- 16% Compare C55 Malignant neoplasm of uterus, part unspecified
- 16% Compare C57.4 Malignant neoplasm, uterine adnexa, unspecified
- 10% Compare C40.2 Malignant neoplasm, long bones of lower limb
- 10% Compare D37.6 Neoplasm of uncertain or unknown behaviour, liver, gallbladder and bile ducts
- 10% Compare D14.3 Benign neoplasm, bronchus and lung
- 10% Compare C18.2 Malignant neoplasm, ascending colon
- 10% Compare C78.7 Secondary malignant neoplasm of liver and intrahepatic bile duct
- 10% Compare C18.4 Malignant neoplasm, transverse colon
- 10% Compare C18.6 Malignant neoplasm, descending colon
- 10% Compare C78.0 Secondary malignant neoplasm of lung
- 10% Compare C18 Malignant neoplasm of colon
- 10% Compare C40.0 Malignant neoplasm, scapula and long bones of upper limb
- 10% Compare B21.0 HIV disease resulting in Kaposi's sarcoma
- 10% Compare C52 Malignant neoplasm of vagina
- 10% Compare C44.1 Malignant neoplasm, skin of eyelid, including canthus
- 10% Compare C40.3 Malignant neoplasm, short bones of lower limb
- 10% Compare C62 Malignant neoplasm of testis
- 10% Compare C62.1 Malignant neoplasm, descended testis
- 10% Compare C41.1 Malignant neoplasm, mandible
- 10% Compare C22 Malignant neoplasm of liver and intrahepatic bile ducts
- 10% Compare C10 Malignant neoplasm of oropharynx
- 10% Compare C62.9 Malignant neoplasm, testis, unspecified
- 10% Compare D16.8 Benign neoplasm, pelvic bones, sacrum and coccyx
- 10% Compare D04 Carcinoma in situ of skin
- 10% Compare D16.5 Benign neoplasm, lower jaw bone
- 10% Compare C41.8 Malignant neoplasm, overlapping lesion of bone and articular cartilage
- 10% Compare C08.0 Malignant neoplasm, submandibular gland
- 10% Compare C96.3 True histiocytic lymphoma
- 10% Compare C78.1 Secondary malignant neoplasm of mediastinum
Learn more about the selection of analogues
▶
- Medical online service designed to help in differential diagnostics.
- Find similar diseases for a diagnosis that causes irritation.
- If you are a professional, then the help of artificial intelligence will help in the express diagnostics.
The advantage of Kiberis is its versatility, thanks to which it is able to select analogues for anything, including for diseases and diagnoses. Artificial intelligence analyzes descriptions of diseases, clinical recommendations for their treatment, real statistics on making diagnoses and displays the most similar diseases with a degree of similarity in percent.